Full Press Release Details
IDEAYA Biosciences Announces Participation at the 42nd Annual J P Morgan Healthcare Conference and 2024 Corporate Guidance.
IDYA
IDEAYA Biosciences Announces Participation at the 42nd Annual J P Morgan Healthcare Conference and 2024 Corporate Guidance
Key Takeaway: IDEAYA Biosciences Announces Participation at the 42nd Annual J P Morgan Healthcare Conference and 2024 Corporate Guidance
Price reaction · baseline $34.3 (2024-01-05 close) · clean, no other IDYA news in the window
day 0 close
+6.6%
day 1
+4.6%
day 3 · peak
+7.7%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+47%
120-day peak, hindsight
Typical move
5.2%
average across 6 past catalysts
Cash runway
~42 mo
Minimal dilution risk
Lead asset
IDE892
Phase 1 · NSCLC Adenocarcinoma